(Q50548714)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234820%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

Excellent outcomes of children with CML treated with imatinib mesylate compared to that in pre-imatinib era (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234820%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234820%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Hideki Muramatsu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234820%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Yoshiyuki Takahashi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234820%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Hirotoshi Sakaguchi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234820%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Nobuhiro Nishio

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234820%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Asahito Hama

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234820%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Sayoko Doisaki

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234820%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Hiroshi Yagasaki

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234820%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Kimikazu Matsumoto

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234820%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Koji Kato

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234820%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Seiji Kojima

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234820%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

14 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234820%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Hematology

20 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234820%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

93

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234820%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234820%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

186-191

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234820%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12185-010-0764-9

20 January 2020

exact match

0 references

cites work

Stem cell transplantation for chronic myeloid leukemia in children

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0764-9

[Prognosis of children with chronic myeloid leukemia: a retrospective analysis of 75 patients]

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0764-9

Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0764-9

Outcome of 125 children with chronic myelogenous leukemia who received transplants from unrelated donors: the Japan Marrow Donor Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0764-9

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0764-9

Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0764-9

Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: results from a Children's Oncology Group phase 1 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0764-9

Imatinib mesylate is effective in children with chronic myelogenous leukemia in late chronic and advanced phase and in relapse after stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0764-9

Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0764-9

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0764-9

Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0764-9

Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0764-9

Is it possible to discontinue imatinib mesylate therapy in Chronic Myeloid Leukemia patients with undetectable BCR/ABL? A case report and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0764-9

Compliance with taking imatinib mesylate in patients with chronic myeloid leukemia in the chronic phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0764-9

Growth deceleration in a girl treated with imatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0764-9

Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Tra

21 January 2018

1 reference

12 December 2020

Chronic leukemias of childhood

1 reference

12 December 2020

Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia

1 reference

12 December 2020

Philadelphia chromosome positive chronic myelocytic leukemia in children

1 reference

12 December 2020

Allogeneic bone-marrow transplantation for chronic myelogenous leukaemia

1 reference

12 December 2020

Allogeneic bone marrow transplantation for chronic myeloid leukemia in childhood: a report from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

1 reference

12 December 2020

10.1007/S12185-010-0764-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21234820%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference